Search for: "SANOFI-PHARMACEUTICALS, INC." Results 21 - 40 of 214
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2022, 12:16 pm by Dennis Crouch
Sanofi (written description requirement). [read post]
23 Sep 2021, 2:10 am by Rose Hughes
The US Courts of Appeal of the Federal Circuit (CAFC) found in Belcher Pharmaceuticals v Hospira, Inc that a formulation patent was unenforceable in view of inequitable conduct, in the form of contradictory submissions to the patent office and the regulatory agency (FDA) by the patentee. [read post]
5 Aug 2021, 7:38 pm by Patent Docs
The product is Semglee (insulin glargine-yfgn), produced by Mylan Pharmaceuticals, Inc., and under this approval, it is interchangeable with Lantus (insulin glargine) made by Sanofi. [read post]
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Companies whose initial vaccine efforts failed, such as Merck & Co. and Sanofi, have partnered with Johnson & Johnson and Pfizer Inc., respectively, to help ramp up vaccine supply. [read post]
14 Jan 2021, 4:40 pm by anne
A $145 million settlement with EHR provider Practice Fusion, Inc., which was alleged to have accepted kickbacks from pharmaceutical companies including Purdue Pharma in exchange for implementing prompts in its EHR system that were designed to increase prescriptions of specific drugs. [read post]
15 Oct 2020, 9:40 pm by Kirk Hartung
” In the first IPR, Sanofi-Aventis, Genzyme Corp., and Regeneron Pharmaceuticals (collectively “Sanofi”) challenged the ‘487 patent, and the PTAB found all of the challenged claims to be invalid. [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
5 Oct 2020, 2:00 am by Annsley Merelle Ward
Settle in with the Chat Français for some French carb loading of delicious, fresh patent decisions from the first half of 2020Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
27 Sep 2020, 6:36 pm by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
19 Aug 2020, 10:58 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsModerna, Inc., a Cambridge, MA-based biotech company, is a leading contender in the race to develop a SARS-CoV-2 vaccine. [read post]